INTERSECT ENT INC (XENT)

US46071F1030 - Common Stock

28.24  0 (0%)

After market: 28.24 0 (0%)

Fundamental Rating

1

We assign a fundamental rating of 1 out of 10 to XENT. XENT was compared to 193 industry peers in the Health Care Equipment & Supplies industry. XENT may be in some trouble as it scores bad on both profitability and health. XENT is valied quite expensively at the moment, while it does show a decent growth rate.



Quickly go to:

0

1. Profitability

1.1 Basic Checks

XENT had negative earnings in the past year.
XENT had negative earnings in each of the past 5 years.
In the past 5 years XENT always reported negative operating cash flow.

1.2 Ratios

Industry RankSector Rank
ROA -132.19%
ROE N/A
ROIC N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

Industry RankSector Rank
OM -75.06%
PM (TTM) -161.94%
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A

More info and screens

1

2. Health

2.1 Basic Checks

Compared to 1 year ago, XENT has more shares outstanding
XENT has a worse debt/assets ratio than last year.

2.2 Solvency

XENT has an Altman-Z score of -5.47. This is a bad value and indicates that XENT is not financially healthy and even has some risk of bankruptcy.
XENT has a Debt/Equity ratio of -1.52. This is a healthy value indicating a solid balance between debt and equity.
Industry RankSector Rank
Debt/Equity -1.52
Debt/FCF N/A
Altman-Z -5.47
ROIC/WACCN/A
WACCN/A

2.3 Liquidity

XENT has a Current Ratio of 1.88. This is a normal value and indicates that XENT is financially healthy and should not expect problems in meeting its short term obligations.
A Quick Ratio of 1.50 indicates that XENT should not have too much problems paying its short term obligations.
Industry RankSector Rank
Current Ratio 1.88
Quick Ratio 1.5

More info and screens

4

3. Growth

3.1 Past

XENT shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -120.27%.
XENT shows a strong growth in Revenue. In the last year, the Revenue has grown by 22.25%.
The Revenue has been growing slightly by 6.29% on average over the past years.
EPS 1Y (TTM)-120.27%
EPS 3YN/A
EPS 5YN/A
EPS growth Q2Q-63.46%
Revenue 1Y (TTM)22.25%
Revenue growth 3Y-0.54%
Revenue growth 5Y6.29%
Revenue growth Q2Q-11.34%

3.2 Future

XENT is expected to show a small growth in Earnings Per Share. In the coming years, the EPS will grow by 3.25% yearly.
XENT is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 19.06% yearly.
EPS Next Y37%
EPS Next 2Y17.73%
EPS Next 3Y8.55%
EPS Next 5Y3.25%
Revenue Next Year14.26%
Revenue Next 2Y19.58%
Revenue Next 3Y18.84%
Revenue Next 5Y19.06%

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

XENT reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for XENT. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA -14.14

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y17.73%
EPS Next 3Y8.55%

More info and screens

0

5. Dividend

5.1 Amount

XENT does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

INTERSECT ENT INC

NASDAQ:XENT (5/12/2022, 7:00:03 PM)

After market: 28.24 0 (0%)

28.24

0 (0%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap954.79M
Analysts
Price Target
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -132.19%
ROE N/A
ROCE
ROIC
ROICexc
ROICexgc
OM -75.06%
PM (TTM) -161.94%
GM N/A
FCFM
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover0.82
Health
Industry RankSector Rank
Debt/Equity -1.52
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio 1.88
Quick Ratio 1.5
Altman-Z
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
Growth
EPS 1Y (TTM)-120.27%
EPS 3YN/A
EPS 5Y
EPS growth Q2Q
EPS Next Y37%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)22.25%
Revenue growth 3Y-0.54%
Revenue growth 5Y
Revenue growth Q2Q
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y